ÂÜÀòÂÒÂ×

Michael Ratcliffe brings more than three decades of experience in the strategy and competitive intelligence and more than a decade of experience researching and analyzing multiple areas of global biopharma and healthcare markets to his roles as practice leader.

His creative consulting approach includes a combination of qualitative and quantitative real-world research skills to help clients understand issues around competitive strategy. He has worked for a number of leading strategic consulting firms including McKinsey & Co, DRI-McGraw Hill, Stanford Research Institute Consulting and Wood Mackenzie.

Prior to joining Fuld + Company, Michael spent many years delivering engagements across multiple areas of the healthcare market from understanding the competitive environment in major hospital systems, specialized clinic markets, retail and specialty pharmacies, pharmaceutical and biotechnology products, diagnostics, delivery devices, pharmaceutical and biologic manufacturing, disease management, electronic medical record systems and health insurance markets.

He has managed projects focused on the U.S. healthcare market, as well as Europe, Latin America and China. He brings in-depth knowledge on the changing structure of the U.S. healthcare market through both federal and state legislation as well as a deep understanding of the key macro forces driving change across the healthcare market. He is frequently invited to deliver seminars at various universities and is slated to publish another CI related book in 2020.